Search

Zoetis Inc

Fermé

SecteurSoins de santé

73.9 1.8

Résumé

Variation du prix de l'action

24h

Actuel

Min

72.59

Max

74.45

Chiffres clés

By Trading Economics

Revenu

90M

691M

Ventes

206M

2.5B

P/E

Moyenne du Secteur

11.84

57.002

BPA

1.87

Rendement du dividende

2.84

Marge bénéficiaire

27.998

Employés

14,500

EBITDA

-12M

927M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+25.63% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

2.84%

2.22%

Prochains Résultats

3 nov. 2026

Date du Prochain Dividende

1 sept. 2026

Date du Prochain Détachement de Dividende

30 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.5B

31B

Ouverture précédente

72.1

Clôture précédente

73.9

Sentiment de l'Actualité

By Acuity

59%

41%

285 / 340 Classement par Healthcare

Zoetis Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 août 2026, 23:36 UTC

Zoetis Inc shares are lower in after-market hours, following a broader market trend amid rising crude oil prices and geopolitical tensions.

14 août 2026, 23:06 UTC

Zoetis Inc. shares are higher in after-market trading, recovering from earlier losses. This movement occurs amid broader economic concerns over declining U.S. retail sales.

13 août 2026, 23:06 UTC

Zoetis Inc. shares moved lower in after-market trading, reflecting a modest decline since Thursday's close. The performance remains within the one-month trading range.

12 août 2026, 20:01 UTC

News

Zoetis Inc. shares are lower as analysts cut price targets amid broader market pressures. Piper Sandler lowered its target from $90 to $80.

11 août 2026, 23:36 UTC

Zoetis Inc. shares traded roughly flat in after-market hours, showing minimal change and stability within the middle of its one-month trading range.

10 août 2026, 23:06 UTC

Correlated Moves
News

Shares of Zoetis Inc. are higher in after-market trading as investor Michael Burry increases his long equity position, citing potential for multi-year stabilization.

8 août 2026, 00:01 UTC

Zoetis Inc. shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics influenced by recent economic data.

7 août 2026, 23:01 UTC

Zoetis shares advanced in after-market trading, showing notable activity despite being below the 20-day moving average and near the lower end of its one-month range.

6 août 2026, 23:26 UTC

News

Zoetis Inc shows a modest advance in after-market trading, now valued at approximately $31.19 billion, ranking as the 298th largest firm by market capitalization.

5 août 2026, 23:41 UTC

Zoetis Inc. shares declined in after-market trading, remaining below their 20-day moving average despite earlier gains. Asian markets, including the Nikkei 225, performed positively.

4 août 2026, 19:26 UTC

Zoetis Inc shares are lower today amid unusual volatility, reaching a session low earlier. No specific news was identified to explain the movement.

3 août 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1 août 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31 juil. 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30 juil. 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29 juil. 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28 juil. 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27 juil. 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25 juil. 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24 juil. 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23 juil. 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22 juil. 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21 juil. 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20 juil. 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Comparaison

Variation de prix

Zoetis Inc prévision

Objectif de Prix

By TipRanks

25.63% hausse

Prévisions sur 12 Mois

Moyen 91.67 USD  25.63%

Haut 115 USD

Bas 80 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

5

Achat

7

Maintien

0

Vente

Sentiment

By Acuity

285 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat